BiotechTube
Advanced Solutions Life Sciences

Advanced Solutions Life Sciences

Louisville, United States· Est.
advancedsolutions.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $13.8M

Overview

Advanced Solutions Life Sciences is a pioneering developer of automated 3D bioprinting systems, centered on its flagship BioAssemblyBot platform. The company provides integrated hardware, software, and consumable solutions to enable the fabrication of complex, biologically relevant tissue models for research and development. Its technology is positioned to accelerate drug discovery, reduce animal testing through New Approach Methodologies (NAMs), and advance the long-term goal of engineered tissues and organs. ASLS is a private company that has gained industry recognition, including a 2025 Product of the Year award for its bioprinting technology.

Regenerative MedicineTissue Engineering

Technology Platform

BioAssemblyBot (BAB) intelligent robotic 3D bioprinting platform integrated with BABIntelligence software (TSIM, BioSegment, BioApps), Angiomics vascularization solutions, and Organoid360 automated workflows for biofabrication of tissue models and organoids.

Funding History

2
Total raised:$13.8M
Series A$12M
Seed$1.8M

Opportunities

The company is positioned at the convergence of several high-growth trends: the rapid adoption of New Approach Methodologies (NAMs) in drug development, the explosive expansion of organoid research, and the long-term vision of regenerative medicine.
Its integrated platform allows it to capture value across research, drug discovery, and preclinical testing markets.

Risk Factors

Key risks include competition in the evolving 3D bioprinting landscape, the capital-intensive nature of hardware development and sales, and dependence on the broader but uncertain pace of adoption of complex 3D models by the pharmaceutical industry and regulatory bodies.

Competitive Landscape

ASLS competes with other 3D bioprinter manufacturers (e.g., CELLINK/BICO, Allevi, Regemat 3D) and providers of organoid culture systems. Its differentiation lies in its emphasis on full automation, industrial robotics, integrated software for design and analysis, and specialized application bundles like Organoid360 and Angiomics.

More companies in Synthetic Biology →More companies in United States →